ZIG
GILD icon

Zurich Insurance Group’s Gilead Sciences GILD Stock Holding History

Zurich Insurance Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.5M Buy
341,130
+33,365
+11% +$4.67M 0.37% 72
2025
Q4 		$37.8M Buy
307,765
+277,065
+902% +$33.7M 0.26% 99
2025
Q3 		$3.41M Sell
30,700
-255,835
-89% -$29.1M 0.02% 160
2025
Q2 		$31.8M Sell
286,535
-28,889
-9% -$3.07M 0.25% 91
2025
Q1 		$35.3M Sell
315,424
-593,470
-65% -$61.2M 0.29% 94
2024
Q4 		$84M Buy
908,894
+635,209
+232% +$57.2M 0.68% 37
2024
Q3 		$22.9M Buy
273,685
+242,985
+791% +$18.5M 0.19% 113
2024
Q2 		$2.11M Hold
30,700
– – 0.02% 154
2024
Q1 		$2.25M Hold
30,700
– – 0.02% 162
2023
Q4 		$2.49M Hold
30,700
– – 0.03% 156
2023
Q3 		$2.3M Buy
+30,700
New +$2.36M 0.02% 151
2022
Q3 		– Sell
-23,900
Closed -$1.48M – 241
2022
Q2 		$1.48M Buy
+23,900
New +$1.48M 0.02% 158
2019
Q4 		– Sell
-256,609
Closed -$16.3M – 332
2019
Q3 		$16.3M Buy
256,609
+8,579
+3% +$561K 0.31% 80
2019
Q2 		$16.8M Buy
248,030
+41,097
+20% +$2.7M 0.33% 72
2019
Q1 		$13.5M Sell
206,933
-41,127
-17% -$2.73M 0.29% 101
2018
Q4 		$15.5M Buy
248,060
+3,542
+1% +$248K 0.37% 81
2018
Q3 		$18.9M Buy
244,518
+26,871
+12% +$2.03M 0.4% 67
2018
Q2 		$15.4M Sell
217,647
-26,357
-11% -$1.86M 0.35% 71
2018
Q1 		$18.4M Buy
244,004
+56,961
+30% +$4.53M 0.42% 55
2017
Q4 		$13.4M Buy
187,043
+21,488
+13% +$1.63M 0.31% 70
2017
Q3 		$13.4M Sell
165,555
-36,148
-18% -$2.76M 0.37% 61
2017
Q2 		$14.3M Buy
201,703
+14,060
+7% +$936K 0.4% 53
2017
Q1 		$12.7M Sell
187,643
-5,108
-3% -$359K 0.37% 59
2016
Q4 		$13.8M Buy
192,751
+23,807
+14% +$1.77M 0.44% 48
2016
Q3 		$13.4M Sell
168,944
-58,255
-26% -$4.73M 0.45% 49
2016
Q2 		$19M Sell
227,199
-5,727
-2% -$508K 0.66% 39
2016
Q1 		$21.4M Sell
232,926
-11,386
-5% -$1.03M 0.76% 31
2015
Q4 		$24.7M Sell
244,312
-29,509
-11% -$3.07M 0.89% 28
2015
Q3 		$26.9M Buy
+273,821
New +$30.4M 0.99% 26

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Zurich Insurance Group's GILD Position: Q1 2026 in Review

Zurich Insurance Group increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $4.67M and bringing the position to 341,130 shares worth $47.5M. The position accounts for 0.37% of the portfolio, ranked #72.

Zurich Insurance Group first reported a position in GILD in Q3 2015 and has held it in 29 quarters since. The position peaked at $84M in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Zurich Insurance Group held 341,130 shares of Gilead Sciences worth $47.5M as of Q1 2026.
  • Zurich Insurance Group bought 33,365 Gilead Sciences shares in Q1 2026, an estimated $4.67M.
  • Gilead Sciences made up 0.37% of Zurich Insurance Group's portfolio in Q1 2026, its #72 holding.
  • Zurich Insurance Group first reported a position in Gilead Sciences in Q3 2015 and has held it in 29 quarters since.
  • Zurich Insurance Group's Gilead Sciences position peaked at $84M in Q4 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.